Home / Stocks / GlaxoSmithKline PLC ADR
GlaxoSmithKline PLC ADR
2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Holding superinvestors
| Superinvestor | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Dodge & Cox Funds | 46,388,219 | $2.18B | 1.7% | Reduced |
| Kahn Brothers Group | 1,587,628 | $74.6M | 9.0% | Reduced |
| Ariel Investments | 1,167,412 | $54.86M | 0.7% | Reduced |
| Tweedy Browne | 171,009 | $8.036M | 0.3% | Reduced |
By quarter
| Quarter | Holders | Total value |
|---|---|---|
| 2013-06-30 | 4 | $3.178B |
| 2013-09-30 | 4 | $3.107B |
| 2013-12-31 | 4 | $3.26B |
| 2014-03-31 | 5 | $3.27B |
| 2014-06-30 | 6 | $3.283B |
| 2014-09-30 | 6 | $1.83B |
| 2014-12-31 | 5 | $1.077B |
| 2015-03-31 | 6 | $1.159B |
| 2015-06-30 | 6 | $599.5M |
| 2015-09-30 | 6 | $94.87M |
| 2015-12-31 | 6 | $94.21M |
| 2016-03-31 | 7 | $98.39M |
| 2016-06-30 | 7 | $108.1M |
| 2016-09-30 | 7 | $118.3M |
| 2016-12-31 | 7 | $113M |
| 2017-03-31 | 5 | $133M |
| 2017-06-30 | 5 | $140.8M |
| 2017-09-30 | 5 | $739.9M |
| 2017-12-31 | 5 | $1.697B |
| 2018-03-31 | 5 | $2.058B |
| 2018-06-30 | 5 | $2.085B |
| 2018-09-30 | 5 | $2.07B |
| 2018-12-31 | 5 | $1.963B |
| 2019-03-31 | 5 | $2.14B |
| 2019-06-30 | 4 | $2.061B |
| 2019-09-30 | 4 | $2.201B |
| 2019-12-31 | 4 | $2.317B |
| 2020-03-31 | 4 | $1.777B |
| 2020-06-30 | 4 | $1.804B |
| 2020-09-30 | 4 | $1.785B |
| 2020-12-31 | 6 | $2.39B |
| 2021-03-31 | 6 | $3.214B |
| 2021-06-30 | 6 | $3.592B |
| 2021-09-30 | 6 | $3.442B |
| 2021-12-31 | 7 | $4.007B |
| 2022-03-31 | 7 | $3.841B |
| 2022-06-30 | 6 | $3.328B |
| 2022-09-30 | 2 | $42.69M |
| 2022-12-31 | 1 | $43.11M |
| 2023-03-31 | 1 | $45.45M |
| 2023-06-30 | 1 | $45.03M |
| 2023-09-30 | 1 | $46.48M |
| 2023-12-31 | 1 | $46.68M |
| 2024-03-31 | 1 | $53.74M |
| 2024-06-30 | 1 | $47.79M |
| 2024-09-30 | 1 | $43.29M |
| 2024-12-31 | 1 | $29.92M |
| 2025-03-31 | 1 | $31.85M |